Does self-stigma impact blood glucose control in people with type 1 diabetes?

Individuals with chronic medical conditions may experience self-stigma, or negative beliefs, emotional reactions, and behaviors towards themselves as a result of their illness. New research published in the Journal of Diabetes Investigation found a link between self-stigma and glycated hemoglobin (HbA1c)—a marker of blood glucose levels—in adults with type 1 diabetes.

The study included 109 adults in Japan with type 1 diabetes who completed questionnaires that generated scores based on a self-stigma scale. Although the findings support a link between self-stigma and sub-optimal HbA1c, additional studies are needed to show whether this is a causal relationship.

“We focused on this issue through clinical experiences with people with type 1 diabetes, whose glycemic management improved markedly by social supports of eliminating diabetes-related stigma. Although the finding of an association between self-stigma and HbA1c is significant, further longitudinal research is required to determine whether self-stigma leads to sub-optimal HbA1c,” said corresponding author Yukiko Onishi MD, PhD, of the Institute of Medical Science, Asahi Life Foundation, in Tokyo. “This research does support and highlight the importance of eliminating self-stigma when treating people with type 1 diabetes.”

URL upon publication: https://onlinelibrary.wiley.com/doi/10.1111/jdi.13963

Additional Information
NOTE: The information contained in this release is protected by copyright. Please include journal attribution in all coverage. For more information or to obtain a PDF of any study, please contact: Sara Henning-Stout, newsroom@wiley.com.

About the Journal
Journal of Diabetes Investigation (JDI) is a peer-reviewed open access journal and the official publication of the Asian Association for the Study of Diabetes (AASD). JDI publishes original research, country reports, reviews, case reports, commentaries, letters, editorials and news. JDI embraces clinical and experimental research in diabetes and related areas including prevention, treatment and molecular aspects and pathophysiology. Translational research focused on the exchange of ideas between clinicians and researchers is also welcomed.

About Wiley
Wiley is one of the world’s largest publishers and a global leader in scientific research and career-connected education. Founded in 1807, Wiley enables discovery, powers education, and shapes workforces. Through its industry-leading content, digital platforms, and knowledge networks, the company delivers on its timeless mission to unlock human potential. Visit us at Wiley.com. Follow us on Facebook, Twitter, LinkedIn and Instagram.